The current document was developed by the working group on the 'application of cardiac magnetic resonance' of the Italian Society of Cardiology to provide a perspective on the current state of technical advances and clinical cardiac magnetic resonance applications and to inform cardiologists how to implement their clinical and diagnostic pathway with the introduction of this technique in the clinical practice. Appropriateness criteria were defined using a score system: score 1-3 U inappropriate (test is not generally acceptable and is not a reasonable approach for the indication), score 4-6 U uncertain (test may be generally acceptable and may be a reasonable approach for the indication but more research and/or patient information is needed to classify the indication definitively) and score 7-9 U appropriate (test is generally acceptable and is a reasonable approach for the indication).
Introduction
The current document was developed by the working group on the 'application of cardiac magnetic resonance (CMR)' of the Italian Society of Cardiology to provide a perspective on the current state of technical advances and clinical CMR applications and to inform cardiologists how to implement their clinical and diagnostic pathway with the introduction of this technique in the clinical practice. Appropriateness criteria were defined using a score system: score 1-3 ¼ inappropriate (test is not generally acceptable and is not a reasonable approach for the indication), score 4-6 ¼ uncertain (test may be generally acceptable and may be a reasonable approach for the indication but more research and/or patient information is needed to classify the indication definitively) and score 7-9 ¼ appropriate (test is generally acceptable and is a reasonable approach for the indication).
Inflammatory cardiac disease
Myocarditis Noninvasive diagnosis of myocarditis can be very difficult in clinical practice due to the high heterogeneity of the clinical presentations in absence of specific ECG and echocardiographic signs. 1, 2 CMR is a valuable diagnostic tool to noninvasively diagnose myocarditis. 3, 4 In 2009, the International Consensus Group on CMR in Myocarditis proposed 'Lake Louise Criteria' for myocarditis. At least two of the following CMR criteria must be present: increased of regional or global myocardial signal intensity in T2-weighted images (edema), increased global myocardial early (3 min) gadolinium enhancement ratio between myocardium and skeletal muscle in gadolinium-enhanced T1-weighted images (hyperemia), nonischemic regional distribution in late gadolinium enhancement (LGE) most frequently involving the subepicardial portion of the lateral left ventricular (LV) wall and less frequently the mid-wall of the interventricular septum. 5 The concomitant existence of skeletal muscle inflammation with edema, observed in acute myocarditis, can lead to false negative results for myocardial edema. 6 Hyperemia identification, as proposed by Lake Louise criteria, is very challenging and poorly used in the clinical setting. Recently, postcontrast cine steadystate free precession (SSFP) sequences were proposed as a new method for hyperemia identification (Fig. 1) . 7, 8 The sensitivity of CMR for the diagnosis of myocarditis is high for infarct-like presentation, low for myocarditis with heart failure and with arrhythmic clinical presentation. CMR findings should be used cautiously in these two latter conditions. 9 The persistence of inflammation in chronic myocarditis is associated with LV dilatation and dysfunction and to tissue abnormalities on CMR, 1 but the role of CMR in assessing chronic myocarditis patients is uncertain. Recent data suggest that chronic myocardial inflammation may be associated with generalized myocardial edema and to an increase of global myocardial enhancement. 10, 11 Recent reports demonstrated that hyperenhancement areas can decrease or even disappear over time. 12, 13 A study of comparison with endomyocardial biopsy (EMB) demonstrated that CMR with LGE is highly accurate to detect acute myocardial inflammation, in which LGE is positive in 95% cases, but it is not sensitive to detect chronic myocarditis (LGE positive in only 40%). 14, 15 CMR may be considered as an appropriate diagnostic tool in hemodynamically stable patients with suspected acute myocarditis (Table  1 ). 1 Based on the different prognosis for acute myocarditis with different clinical and instrumental presentations, endomyocardial biopsy should be reserved in patients with clinical worsening despite pharmacological treatment, and it should be preferred with respect to CMR in unstable patients. 16 Preliminary data suggest that the early use of CMR reduces hospitalization time and costs. 17 
Pericarditis
Pericardial abnormalities observed in pericarditis (effusion, acute or chronic inflammation) can be easily identified by CMR. 18 T1-weighted fast spin echo (FSE) allows the distinction between transudative (hypointense) and exudative (hyperintense) pericardial effusion. SSFP images allow detection of fluid (hyperintense) or dense exudation (intermediate intensity). Finally, T2-weighted imaging permits visualization of edema of the inflamed pericardial layers (hyperintense layers). At LGE, hyperintensity of pericardial layers is caused by the presence of active inflammation with granulomatous tissue, edema and neoangiogenesis. 19 In chronic recurrent pericarditis, CMR-guided therapy is associated with a reduction of recurrences. 20 Acute pericarditis may evolve in chronic inflammation and/or constrictive pericarditis. The thickening of pericardial layers is the typical morphological finding in constrictive pericarditis: a thickness more than 4 mm is suggestive for pericardial constriction, whereas more than 5-6 mm had high specificity for pericardial constriction. 21, 22 Other morphofunctional abnormalities of constriction are right ventricular (RV) tubular shape, dilated atria, dilated caval/hepatic veins, septal bouncing and/or shift in early diastolic ventricular filling on real-time cine CMR during inspiration due to decreased pericardial compliance. 22 CMR has also the advantage to differentiate between atypical forms of constriction as transient constriction (with demonstration of active inflammation in T2-weighted images and LGE) and effusive-constrictive forms (with combined effect of focal constriction and pericardial effusion) that may resolve after appropriate therapy. 23 
Nonischemic cardiomyopathies
Dilated cardiomyopathy CMR is the gold standard technique to assess ventricular volumes, mass and functional parameters as stroke Cardiac MRIs of a case of 'infarct like' presentation of acute myocarditis. In T2-STIR image, myocardial hyperintensity of edema is found in inferior and inferolateral wall. In steady-state free precession images (SSFP), acquired early after gadolinium injection, hyperemia is detectable as well as positive LGE in the same myocardial regions. volume and ejection fraction. In patients with newly diagnosed LV dysfunction, the pattern of presentation of LGE is very accurate to predict the ischemic and nonischemic cause. 24 In the ischemic LV dysfunction, LGE is confluent, with constant involvement of subendocardium and with a coronary-related regional distribution. 25, 26 In the nonischemic-dilated cardiomyopathy (NIDCM), LGE is absent or distributed as a mid-wall stria, patchy or with a subepicardial distribution. Several studies investigated the role of LGE as a predictor of adverse remodeling and worse prognosis. The prevalence of LGE in NIDCM is 25-28% and is associated with increased risk of all-cause mortality and hospitalization for heart failure. 27, 28 The strongest additive value of LGE is to identify patients at risk for sudden cardiac death (SCD): LGE is associated with an increased risk of SCD/ aborted SCD of more than five times compared with patients without, having an additive value to ejection fraction for the identification of patients suitable for primary prevention implantable cardioverter defibrillator. [28] [29] [30] Arrhythmogenic cardiomyopathy The diagnosis of arrhythmogenic RV cardiomyopathy (ARVC) is challenging, and it is based on a group of structural, histologic, ECG and family history criteria, proposed and modified by a dedicated task force in 2010 ( Table 2 ). 31 CMR takes part of these criteria for the qualitative evaluation of regional wall motion (akinesia, dyskinesia or dyssynchronous contraction) and global quantification of RV size and systolic function with specific cutoff values. A major criterion is fulfilled in presence of regional RV akinesia or dyskinesia or dyssynchronous RV contraction combined with RV end-diastolic indexed volume (EDVi) at least 110 ml/ m 2 (man) or at least 100 ml/m 2 (woman) or with a RV ejection fraction 40% or less; a minor criterion is satisfied when regional RV akinesia or dyskinesia or dyssynchronous RV contraction is combined with a ratio of RV EDVi at least 100 to less than 110 ml/m 2 (man) or at least 90 to less than 100 ml/m 2 (woman), or with a RV ejection fraction more than 40 to 45% or less. To better visualize wall motion abnormalities, the study of the RV should include short-axis, transaxial stack of cines and long-axis images. Tissue characterization should be preferably performed using FSE sequences, acquired in the axial and short-axis planes for best RV free wall and RV outflow tract evaluation. Identification of fat in the RV, as disruption of the smooth interface between epicardial surface and RV wall (evaluated in FSE images with and without fat saturation), and detection of fibrosis (using LGE technique) are not part of the current task force criteria, because of lack of specificity, high interobserver variability, as well as some technical limitations, due to the thin RV wall thickness. [32] [33] [34] [35] [36] LV abnormalities (diffuse or regional LV dysfunction, mid-wall or subepicardial LV LGE) are not uncommon in ARVC patients and may represent more advanced stages of the disease. 35 However, many concerns were raised about new CMR criteria. 37 In fact, quantitative cutoff for task force criteria were derived from the MESA study. In the MESA study, ventricular volume was measured using the obsolete fast gradient echo pulse sequence, instead of the widely used SSFP sequences. 38 SSFP images provide superior contrast between blood and endocardium, with less blood flow dependence. 39, 40 Also, the revised task force criteria Cine-bSSFP in short-axis and long-axis views T2 STIR in short-axis and long-axis views T1 FSE in short-axis and long-axis views LGE in short-axis and long-axis views Acute pericarditis 6 I C second-level testing for diagnostic work-up in pericarditis. Evaluation of myocardial involvement
As above
Chronic or recurrent pericarditis 8 -As above Suspect of constrictive pericarditis 9 I C to assess pericardial thickness, degree and extension of pericardial involvement Cine-bSSFP in short-axis and long-axis views Real-time cine in short-axis views T2 STIR in short-axis and long-axis views T1 FSE in short-axis and long-axis views LGE in short-axis and long-axis views CAD, coronary artery disease; CMR, cardiac magnetic resonance; FSE, fast spin echo; STIR, Short-Tau Inversion Recovery. Appropriateness criteria: 1-3 inappropriate; 4-6 uncertain;7-9 appropriate.
used MESA patients whose mean age was 60 years, whereas ARVC patients were 20-30 years younger on average. This point is quite relevant because RV enddiastolic volume decreased 4.6% per decade in healthy controls. 38 Yet, recent evidence suggests that LV involvement in ARVC is very frequent and associated with higher risk or arrhythmic events. Notwithstanding, LV involvement is not mentioned in the task force criteria for CMR.
Moreover, despite the fact that fat infiltration, LGE and LV involvement detected by CMR were not included in current task force criteria, they remain important findings of CMR in ARVC, with a demonstrated prognostic relevance 41, 42 (Fig. 2 ).
Cardiac amyloidosis
The presence and severity of cardiac involvement in immunoglobulin light-chain and transthyretin amyloidosis are crucial for prognosis and therapeutic options. [43] [44] [45] CMR represents a good alternative to echocardiography to evaluate morphology and function and to depict a broader range of differences between the two main amyloidosis types. [46] [47] [48] LGE technique has an excellent diagnostic accuracy for the diagnosis of cardiac amyloid. The 'typical' pattern of LGE consisting in a diffuse subendocardial enhancement with a noncoronary distribution, coupled with abnormal gadolinium kinetics of myocardium and blood pool (early darkening of blood pool, nulling defect of myocardium) are pathognomonic of cardiac amyloidosis ( Fig. 3a ). [49] [50] [51] However, some variants of this typical LGE pattern may sometimes be found, presenting with localized, transmural or patchy enhancement.
LGE may also involve RV myocardium and atrial walls. [52] [53] [54] Up to now, a standardized LGE approach to detect cardiac amyloid infiltration is lacking, and in the early stage of cardiac involvement LGE may be negative. Accordingly, the presence of a negative LGE should not exclude cardiac amyloid when pretest probability is high. 55 Phase-sensitive inversion recovery sequences are under evaluation as an operator-independent alternative to the standard LGE technique. 56 Similarly, the measurement of native T1 and extracellular volume (ECV) are promising techniques for the early 4 Journal of Cardiovascular Medicine 2017, Vol 00 No 00 diagnosis of cardiac amyloids. [57] [58] [59] [60] [61] However, further and larger studies are needed to confirm preliminary results.
Hypertrophic cardiomyopathy
Over the last decade, CMR has emerged as an important imaging technique to provide additional information to characterize the broad spectrum of phenotypic expression of this complex disease due to its high spatial resolution, ability to obtain images in any plane and clear definition between the interface of blood pool and myocardium. Therefore, its diagnostic role is particularly relevant in patients with suboptimal images from echocardiography as established by ACC/AHA and by the more recent ESC guideline for the diagnosis and treatment of hypertrophic cardiomyopathy (HCM) (Class I, level B) (Table 3) . 62, 63 CMR provides precise wall thickness measurements in any location of the LV and RV and is superior to echocardiography to detect focal hypertrophy limited to anterior wall or apex, apical aneurysms. [64] [65] [66] [67] [68] [69] Cine images of 5 mm thickness may improve the yield of detection of microaneurysm and crypts. The guidelines suggest to consider CMR in suspected cases of apical hypertrophy or aneurysm (Class IIa, level C). 63 In genotype-positive phenotype-negative patients, CMR can show subtle phenotypic markers of the disease including papillary muscles abnormalities, myocardial crypts, elongated leaflets of the mitral valve and increased myocardial trabeculae. [70] [71] [72] [73] [74] [75] [76] [77] [78] CMR has been also used to evaluate the consequence of septal alcohol ablation and myectomy. [79] [80] [81] Lastly, CMR should be considered to evaluate the presence, the distribution and the extent of myocardial fibrosis that may help to distinguish among differential diagnosis (for example from cardiac amyloidosis or from secondary hypertrophy) and phenotype (Fig. 3b ).
Multiple studies reported high prevalence of LGE in HCM, predominantly as a patchy mid-wall pattern involving areas of hypertrophy or at the RV insertion points. [82] [83] [84] Some studies reported a relationship between LGE and cardiac outcome in HCM patients, [85] [86] [87] [88] and a recent multicenter study demonstrated that the extent of LGE at least 15% of LV mass was associated with worse prognosis. 89 However, LGE is not yet considered a major risk marker of SCD by current ESC guidelines.
Anderson-Fabry disease LV hypertrophy is a common cardiac manifestation in Anderson-Fabry disease (AFD). Differential diagnosis of AFD versus other causes of LV hypertrophy and detection of early cardiac involvement is important given existing specific replacement enzyme therapy.
CMR provides complementary data to echocardiography in AFD especially through its ability to identify tissue characterization.
LGE is a frequent finding in AFD patients and is located particularly in the basal inferolateral LV wall. [90] [91] [92] Recently, preliminary results suggest that the T1 mapping technique held the potentiality to discriminate AFD (low myocardial T1) among patients with LV hypertrophy and to detect early stage. [93] [94] [95] Further larger studies are required to support these findings.
Clinical recommendations of cardiac magnetic resonance Pontone et al. 5 A case of arrhythmogenic right ventricular cardiomyopathy. Fast spin echo images shows fat infiltration in the subtricuspidalic wall and in lateral free wall of right ventricle as well in left lateral wall. In the same region, LGE is also positive in the same regions. LGE images are useful for the differential diagnosis between cardiac amyloidosis (a) and hypertrophic cardiomyopathy (b). In cardiac amyloidosis, LGE image shows diffuse subendocardial enhancement and early darkening of blood. In hypertrophic cardiomyopathy, LGE image shows focal intramural fibrosis in the hypertrophied septum.
Hemocromatosis
Iron overload cardiomyopathy (IOC) results from the accumulation of iron in the myocardium mainly due to genetic disorders of iron metabolism or multiple transfusions (such as in thalassemia). Heart failure secondary to iron overload remains one of the main causes of mortality in IOC. However, IOC can be reversed by chelation therapy. 96 The highly sensitive and reproducible CMR T2 Ã technique has revolutionized IOC management, providing for the first time a direct, noninvasive, quantitative assessment of cardiac iron deposit 97 for first diagnosis and for the titration of iron chelation therapy. 98 Specifically, the multislice approach 99 can detect the uneven iron accumulation in the heart and allows identification of patients at risk for cardiac complications in a precocious stage. 100 A T2 Ã value less than 20 ms is considered the conservative cutoff for segmental and global heart iron. The first cardiac T2 Ã assessment should be performed as early as possible without sedation in patients with hemochromatosis. 101 Moreover, due to the multifactorial etiopatogenesis of cardiomyopathy in hemocromatotic patients, it is recommended a multiparametric CMR approach by a conventional evaluation of cardiac function, myocardial fibrosis by LGE technique 102 and edema when myocarditis is suspected.
Noncompaction cardiomyopathy LV noncompaction cardiomyopathy (LVNC) is a primary genetic cardiomyopathy characterized by the presence of an extensive noncompacted myocardial layer lining the cavity of the LV, probably due to a failure of trabecular remodeling during embryogenesis with the persistence of multiple, prominent ventricular trabeculae separated by deep intertrabecular recesses. 103 After the first echocardiographic suspicion, CMR is recommended to confirm the morphological diagnostic criteria. Petersen et al. 104 reported that the finding of a ratio of more than 2.3 between the thickness of the noncompacted and compacted myocardial layers in diastole at least at one myocardial segment is diagnostic. However, these criteria have reduced specificity particularly when used in a population with low pretest probability of LVNC. More complex diagnostic criteria are currently under evaluation. 105, 106 Patients with HCM or carriers of sarcomeric mutation may present with a 6 Journal of Cardiovascular Medicine 2017, Vol 00 No 00 
Sarcoidosis
Sarcoidosis is a systemic granulomatous disease involving the heart in 20-30% of the cases at autopsy. 108 Because of the focal myocardial involvement, endomyocardial biopsy yields low sensitivity. Moreover, most noninvasive diagnostic techniques have a low sensitivity and specificity. CMR is able to detect all phases of the pathological features of cardiac sarcoidosis characterized by noncaseating epitheloid granulomatous infiltration: focal wall thickening in cine images, edema on T2-Short Tau Inversion Recovery (STIR) images, gadolinium enhancement on early and late images. 109, 110 CMR is also able to assess the response of the inflammation to immunosuppressive treatment that can improve the prognosis. Unfortunately, CMR cardiac findings in sarcoidosis are nonspecific and can be found in myocarditis, in cardiac lymphoma and mimic myocardial infarction. Moreover, CMR can evaluate impairment of cardiac function, pericardial effusion and hilar or mediastinal lymphadenopathy.
Chagas cardiomyopathy
In Chagas cardiomyopathy, CMR can be used as an accurate and detailed assessment of the ventricular volumes, function and segmental contractility. CMR is also able to detect complications as ventricular aneurysms with parietal thinning and the presence of intracavitary thrombus. Reparative fibrosis is characteristic of this cardiomyopathy and is believed to be responsible for many aspects of its poor prognosis. Fibrosis is related to severe ventricular arrhythmias, heart failure, sudden death and other major events. CMR with LGE technique allows detection and quantification of myocardial fibrosis. T1 and T2 mapping are under evaluation for the identification of early myocardial involvement.
Cardiotoxicity Chemotherapy-induced cardiotoxicity shows an increasing incidence and represents a significant determinant of quality of life and mortality during ongoing treatment and in long-term survivors of cancer. Echocardiography remains the most used method to monitor cancer patients, but CMR is a valid second-line imaging modality (Table 4 ).
Based on the recent joint consensus document of the EACVI/ASE, the use of CMR in the clinical setting is strictly recommended for quantification of LV ejection fraction when the quality of echocardiogram is suboptimal; confirming a LV ejection fraction less than 53% by echocardiogram; during the follow-up, for the LV ejection fraction quantification in cases of possible discontinuation of chemotherapy; and when LV ejection fraction estimation by echocardiogram is controversial. 111 Anyway, the CMR incremental value is also for detecting early cardiac injury, quantifying RV function and cardiac mass, and monitoring chemotherapy-treated patients over time, whose management depends on minimal variations in biventricular function parameters.
Takotsubo cardiomyopathy
Takotsubo cardiomyopathy (TTC), called also 'stressinduced cardiomyopathy' and/or 'transient LV apical ballooning syndrome', is an acquired cardiomyopathy characterized by transient regional wall motion abnormalities (usually in mid-apical segments of LV) not related with stenosis of a coronary artery, that is provoked by pronounced negative emotional, psychological or physical stress. CMR should be considered for the differential diagnosis between TTC and acute coronary syndrome. The typical CMR findings in TTC are regional wall motion abnormalities in apical and mid-LV segments added with a possible presence of global LV dysfunction and/or LV dilatation, myocardial edema detected using T2-W images in apical and mid-LV segments, absence of myocardial LGE (mild-intensity LGE described 10-40% of cases and related to interstitial edema), and resolution at 3 months of CMR abnormalities. 112, 113 Cardiac transplantation The mainstays of posttransplant graft surveillance are echocardiography, coronary angiography and endomyocardial biopsy providing assessment of cardiac function and detection of manifestations of both acute rejection and cardiac allograft vasculopathy. CMR may be used in patients with inadequate acoustic window to evaluate cardiac function and volumes. Its higher reproducibility permit identification of early changes in ventricular volume and minimal decrease of ejection fraction as well as the acute increment of LV mass. Myocardial T1 and T2 are increased in the acute phase following transplantation, then T2 shortens. Several studies demonstrated that an increase of myocardial T2 (60 ms) is highly predictive of acute rejection.
LGE may present subepicardial enhancement but it is not sensitive. T1 mapping and ECV measurement are currently under study for the evaluation of acute rejection. The use of CMR stress perfusion with vasodilators is sensitive to detect severe cardiac allograft vasculopathy but its accuracy drops significantly in the presence of mild disease when compared with coronary angiography.
Cardiac tumors and pseudotumors
Primary cardiac tumors can occur in all age groups and are rare, with an estimated cumulative prevalence of 0.002- 0.3% at autopsy. 112 Approximately 75% are histologically benign, and the most common are myxomas, papillary fibroelastomas, lipomas and hemangiomas in the adult population, rhabdomyomas, fibromas and teratomas in children. Almost all malignant primary cardiac tumors are sarcomas, with angiosarcoma being the commonest in adults and rhabdomyosarcoma in children. In autopsy studies, metastatic involvement of the heart (mainly from bronchogenic carcinoma, lymphoma/leukemia and carcinomas of the breast and esophagus) is largely more prevalent than primary cardiac tumors. 113 Dark and bright blood images in the axial, coronal and sagittal planes covering the entire chest and base to apex short-axis and long-axis views should be included in the CMR study. Considering its wide availability and convenience, echocardiography is typically the first-line modality in assessing patients with cardiac masses, but CMR is required to obtain a complete noninvasive characterization. In some cases, cardiac computed tomography (CT) is also included in the diagnostic work-up.
CMR images allow the definition of any cardiac mass in terms of location, size, extension, motility, hemodynamic impact, tissue characteristics and signs of malignancy. Tissue characteristics can be inferred from signal properties assessed on images obtained with different scan sequences. A typical imaging protocol for the study of cardiac masses with CMR includes cine images (SSFP), precontrast morphologic images (T1-weighted FSE with and without fat saturation; T2-weighted FSE with fat saturation), and postcontrast images (first-pass perfusion module and late gadolinium enhancement module). 114 The identification of the nature of a mass involving the heart is reached by combining information about location, morphology and signal characteristics ( Fig. 4) .
Benign cysts represent a common incidental finding on CMR studies and are frequently detected at the pericardial level. Pericardial cysts appear as fluid-filled well demarcated structures, with a homogeneous appearance and variable possible location (common in the right cardiophrenic angle).
Late gadolinium enhancement CMR imaging is the most sensitive technique in the detection of thrombi in dysfunctional LV and should be favored over echocardiography for this application. 115 Thrombi area avascular structures typically show a complete absence of gadolinium accumulation. This behavior in postcontrast images may be useful when an atrial tumor (generally a myxoma in the left atrium) needs to be differentiated from a possible thrombus. 116 The so-called pseudo-masses, which are normal anatomical variants mimicking a mass, such as false tendons, persistent venous valves and the crista terminalis, can be easily differentiated from pathological cardiac masses using CMR techniques.
Differential diagnosis between benign versus malignant masses
Malignant tumors often have typical features on CMR images: common appearance as a broad-based bulky mass with indistinct margins (usually >5 cm in size); signal heterogeneity on different scan sequences, generated by the possible presence of areas of necrosis and hemorrhage; infiltrative signs (i.e. annular or tissue plane crossing within the heart, coexistent involvement of cardiac and extracardiac structures and vascular invasion); signal enhancement during first-pass perfusion and at LGE, with areas of necrosis and hemorrhage; and metastatic lesions observed in other organs. However, the absence of these morphologic elements does not necessarily exclude the detection of malignant tissue by histology, and therefore the ability to distinguish benign from malignant cardiac tumors with CMR is only moderate. 116, 117 Associated findings may include pleural or pericardial effusion, that is common with malignant masses and infrequent with benign neoplasms and nonneoplastic conditions.
Advantages of cardiac magnetic resonance versus other imaging modalities CMR provides images at good spatial and temporal resolution that allow definition of the anatomical extent of a mass involving cardiac and/or extracardiac structures, with the possibility to assess any associated functional consequence. Unlike echocardiography, there are no limitations with regard to imaging windows, field of view or assessment of the right heart involvement. CT has some major disadvantages represented by the use of ionizing radiation and the need for iodinated contrast media, with associated risk of nephrotoxicity and potential higher risk for allergic reactions. A major advantage of CMR is a better capacity to perform tissue characterization over both echocardiography and cardiac CT. However, when compared with CMR, echocardiography is less expensive and more available, whereas cardiac CT allows faster acquisition sessions (few seconds versus 30-45 min) and is able to demonstrate calcification.
Congenital heart disease
Congenital heart diseases (CHD) are the main congenital diseases present at birth. Echocardiography remains the first diagnostic tool for CHD evaluation; however, over the past decades, clinical indications for CMR are rapidly evolving due to its capability to provide invaluable cardiac anatomical and functional information. [118] [119] [120] CMR approach in pediatric CHD is particularly challenging and needs to be adapted to patient size and heart 121 ; moreover, in children less than 8 years old, deep sedation or anesthesia is necessary. Strategy of sedation/anesthesia depends on center availability and expertise. [122] [123] [124] Breath hold sequences are generally preferred but, in small children or in deep sedation, free-breathing scan may be the only option. In this case, artifacts from respiratory motion are usually minimized using multiple averages (or number of excitations) or by a diaphragm tracking using navigator algorithm.
Detailed CMR protocols for each CHD is beyond the scope of this article and have been published elsewhere. 120, 125, 126 In this paragraph, we would like to highlight the asset of CMR for preprocedural and postprocedural evaluation of CHD and appropriate indications criteria.
How to scan a patient with a congenital heart disease Anatomical details are best seen using FSE pulse sequence because of higher resolution than cine imaging and less susceptibility to the artifacts caused by metallic implants. However, SSFP sequence is most frequently used in CHD due to faster acquisition and the possibility to assess regional wall motion, flow turbulences and for functional assessment. The thickness, field of view and voxel size have to be adjusted to patients size and heart rate, an in-plane resolution of 1.2-2 mm and slice thickness of 4-6 mm are recommended in infant and small children. 121 Free-breathing three-dimensional whole- heart SSFP sequence may be used to obtain a first assessment of cardiac without the need of contrast agents and to plan the rest of the examination in patients with complex anatomy. Three-dimensional whole-heart 'time-of-flight' (TOF) images covering the thorax from the aortic arch to the diaphragm may be a valid alternative of three-dimensional SSFP in presence of flow and motion artifact. However, TOF images are very time expensive, requiring several minutes of acquisition time.
Contrast-enhanced magnetic resonance (MR) angiography is routinely used in CHD for the evaluation of vessels anatomy. 127 The timing of image acquisition is tailored to the vessels that need to be assessed, and an appropriate spatial resolution has to be adjusted according to patient size.
Flow assessments in CHD are one of the most important assets of CMR and are performed by means of an acquisition of so-called velocity encoded phase contrast (VEPC) pulse sequences. Clinical applications include measurement of shunt (Q p /Q s ), lung perfusion, cardiac output, valvular regurgitation (mainly semilunar valves), intracardiac baffles and aortopulmonary collateral flow. [128] [129] [130] Free-breathing acquisition with multiple average signals are advised to reduce respiratory motion. Common pitfalls of VEPC are misalignment with flow, turbulent flow, malpositioning with regard to valve plane, through plane motion, effects of breathing, effects of eddy currents and other artifacts, and incorrect setting of velocity encoding. 121 Technical details of VEPC were reported in a recent review of the working group on the 'application of CMR' of the Italian Society of Cardiology. 131 Four-dimensional MR flow is a promising technique that allows acquisition of blood flow information for all vessels included in the three-dimensional imaging volume at the same time under the same physiological status. 132 LGE is usually performed in adult CHD because the presence of myocardial fibrosis has been demonstrated to be associated with adverse cardiac event, 133, 134 although the complete physiopathology is not yet elucidated.
Potential advantages of CMR versus other imaging modality: Transthoracic echocardiography is the first-line tool for the diagnosis and follow-up of patients with CHD due to its low cost, widespread diffusion, portability, ease of use and excellent temporal-spatial resolution. However, its diagnostic utility diminishes with the growth and after surgical procedures. Moreover, echocardiography has limited value for the evaluation of extracardiac structures. Diagnostic cardiac catheterization carries risk of complications and is associated with radiation exposure; furthermore, as a projection technique, it is limited in providing accurate anatomical information. The accuracy of CT in the evaluation of thoracic vessels and the tracheobronchial tree is now well established. CT scanners are also readily available and easy to use compared with CMR and could be preferred in the anatomical evaluation of sick or instable infant. A major disadvantage of CT, especially in children, is the exposure to ionizing radiation with a potential risk of development of radiation-induced malignancies particularly in children.
Although long-time scan, technically complex and expensive, CMR is an invaluable tool in the prerepair and postrepair CHD thanks to its accuracy in the assessment of biventricular volumes, function, myocardial viability and fibrosis; ability to assess intracardiac and extracardiac anatomy with multiplanar and threedimensional reconstruction; and accurate quantification of blood flow volume without any spatial limitation. Moreover, CMR is noninvasive nonionizing tool and therefore is suitable for follow-up evaluation of CHD.
Appropriate use criteria in preoperative and postoperative CHD: Because of the wide range of clinical and hemodynamical findings in prerepair and in postrepair CHD, we chose to propose appropriate use criteria for specific information commonly addressed to CMR or other imaging tool rather than in each single CHD ( Table 5 ).
